Dengue Virus Genotyping(For Research Purpose Only) at Chughtai Lab

Dengue Virus Genotyping(For Research Purpose Only) at Chughtai Lab

Dengue virus (DENV) is a major public health concern globally and particularly in Pakistan, where seasonal outbreaks pose severe challenges to the healthcare system. The virus is a single-stranded positive-sense RNA virus belonging to the family Flaviviridae and genus Flavivirus. It is transmitted primarily by the bite of infected female Aedes mosquitoes, specifically Aedes aegypti and Aedes albopictus. Dengue virus exists as four antigenically distinct serotypes: DENV-1, DENV-2, DENV-3, and DENV-4. Within each serotype, there are multiple distinct genetic lineages known as genotypes. The Dengue Virus Genotyping(For Research Purpose Only) at Chughtai Lab is a highly specialized molecular assay designed to identify and characterize these specific genotypes and serotypes for research, academic, and epidemiological purposes.

This advanced molecular test does not merely detect the presence of the virus; rather, it decodes its genetic blueprint. By targeting highly conserved and variable regions of the viral genome—most notably the Envelope (E) gene or the pre-membrane/Envelope (prM/E) junction—the assay allows researchers to classify the virus into its respective serotypes and genotypes. The technology utilized for this process typically involves reverse transcription polymerase chain reaction (RT-PCR) followed by Sanger sequencing, next-generation sequencing (NGS), or multiplex real-time PCR with genotype-specific probes. This level of genetic resolution is critical for understanding the molecular epidemiology of dengue in Pakistan, tracking the introduction of novel viral lineages, and monitoring genetic mutations that may influence viral transmission dynamics, virulence, or diagnostic escape.

While routine diagnostic tests such as NS1 antigen rapid tests, IgM/IgG serology, and standard qualitative RT-PCR are used for clinical diagnosis and patient management, they do not provide information regarding the specific genotype of the infecting strain. The Dengue Virus Genotyping(For Research Purpose Only) assay fills this critical gap for the scientific and medical research community. It provides invaluable diagnostic and research value by enabling phylogenetic analysis, mapping viral evolution, and assisting in the development of targeted public health interventions. Understanding which genotypes are circulating within specific geographical regions of Pakistan is essential for predicting the severity of outbreaks, as certain genotypes, such as the DENV-2 Cosmopolitan genotype, have been historically associated with higher rates of severe clinical manifestations like Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS).

Clinical Procedure: What to Expect

Patient Preparation

Because the Dengue Virus Genotyping(For Research Purpose Only) is a molecular laboratory test performed on a blood sample, patient preparation is straightforward but requires strict adherence to clinical protocols to ensure sample integrity. Patients and researchers should observe the following preparation guidelines:

• No Fasting Required: There is no requirement for fasting before this test. The patient may eat and drink normally prior to sample collection.
• Medication Disclosure: It is vital to inform the healthcare provider of all current medications, particularly anticoagulants (blood thinners) such as warfarin, heparin, or aspirin, as these can affect bleeding times at the venipuncture site.
• Research Documentation: Since this test is designated “For Research Purpose Only,” patients or clinical trial participants must complete and sign the appropriate informed consent forms and research questionnaires required by the investigating institution or Chughtai Lab.
• Hydration: Adequate hydration is highly recommended before the blood draw, as it makes the veins more accessible and facilitates a smoother venipuncture process.
• Timing of Collection: For optimal viral RNA recovery, the sample should ideally be collected during the acute phase of viremia, typically within the first 3 to 7 days of symptom onset.

During the Procedure

The sample collection for Dengue Virus Genotyping(For Research Purpose Only) follows standard aseptic venipuncture protocols to ensure patient safety and prevent sample contamination. The procedure is conducted as follows:

• Patient Positioning: The patient is seated comfortably in a blood collection chair, or placed in a recumbent position if they have a history of vasovagal syncope (fainting).
• Site Selection and Preparation: A trained phlebotomist identifies a suitable vein, typically in the antecubital fossa of the arm. The skin is thoroughly cleansed with an antiseptic solution (such as 70% isopropyl alcohol) using a circular motion and allowed to air dry completely to prevent hemolysis and contamination.
• Tourniquet Application: A tourniquet is applied a few inches above the selected site to increase venous pressure and make the vein more prominent. The tourniquet is left in place for no more than one minute.
• Venipuncture: Using a sterile, single-use needle attached to a vacuum collection tube, the phlebotomist gently inserts the needle into the vein. For molecular testing, blood is typically collected in an EDTA (purple top) tube or a serum separator tube (SST/gold top), depending on the specific laboratory protocol.
• Sample Volume: Approximately 3 to 5 milliliters of venous blood is drawn to ensure an adequate volume of serum or plasma for RNA extraction and subsequent sequencing.
• Post-Draw Care: The needle is smoothly withdrawn, and immediate, gentle pressure is applied to the puncture site with a sterile gauze pad. An adhesive bandage is applied once bleeding has stopped.
• Specimen Processing and Transport: The collected sample is immediately inverted gently 8-10 times to mix with the anticoagulant (if EDTA is used). It is then centrifuged to separate the plasma or serum. The separated specimen is stored at ultra-low temperatures (-80 degrees Celsius) or transported on dry ice to the molecular diagnostics department at Chughtai Lab to prevent the degradation of fragile viral RNA.

When is a Dengue Virus Genotyping(For Research Purpose Only) Performed?

Epidemiological Surveillance and Outbreak Tracking

This test is performed during major seasonal outbreaks of dengue in Pakistan to identify which specific genotypes are driving the epidemic. Public health authorities and researchers utilize genotyping to track the geographical movement of the virus across different provinces and cities, helping to map out high-risk zones and implement vector control measures effectively.

Academic and Clinical Research Studies

Academic institutions and clinical researchers request this assay to study the genetic diversity of the Dengue virus. By analyzing the sequence data obtained from genotyping, researchers can investigate host-pathogen interactions, viral mutation rates, and evolutionary changes in the viral genome over time, contributing to the global scientific understanding of flaviviruses.

Vaccine Efficacy and Development Trials

With the ongoing development and deployment of dengue vaccines globally, genotyping is crucial in clinical trials to evaluate vaccine efficacy. It helps researchers determine if a vaccine provides equal protection against all circulating genotypes in a specific region or if breakthrough infections are associated with specific genetic variants of the virus.

Investigating Severe Dengue Associations

Physicians and clinical investigators utilize genotyping to study the correlation between specific viral genotypes and the severity of clinical disease. Since secondary infections with a different serotype can lead to severe complications due to antibody-dependent enhancement (ADE), identifying the precise genotype helps researchers understand why certain outbreaks result in higher rates of hospitalization and hemorrhagic manifestations.

Phylogenetic Analysis and Viral Mapping

This test is performed when researchers need to conduct phylogenetic analysis to trace the evolutionary origin of a circulating strain. It allows scientists to determine whether a dengue outbreak is caused by an endemic strain that has mutated or if a new genotype has been imported into Pakistan from another country through international travel and commerce.

What Does a Dengue Virus Genotyping(For Research Purpose Only) Detect?

The Dengue Virus Genotyping(For Research Purpose Only) assay is designed to detect and characterize specific molecular targets within the viral genome. The assay can identify and report the following clinical and scientific findings:

• Presence of Dengue Virus RNA: Confirms the detection of viable genomic material of the Dengue virus in the patient’s specimen.
• Absence of Dengue Virus RNA: Indicates that viral RNA was not detected or was below the analytical limit of detection of the assay.
• DENV-1 Serotype: Identifies the presence of Dengue virus serotype 1.
• DENV-2 Serotype: Identifies the presence of Dengue virus serotype 2.
• DENV-3 Serotype: Identifies the presence of Dengue virus serotype 3.
• DENV-4 Serotype: Identifies the presence of Dengue virus serotype 4.
• DENV-1 Genotype I: Detects the specific Genotype I lineage within the DENV-1 serotype.
• DENV-1 Genotype II: Detects the Genotype II lineage of DENV-1.
• DENV-1 Genotype III: Detects the Genotype III (sylvatic/somatic) lineage of DENV-1.
• DENV-1 Genotype IV: Identifies the Genotype IV lineage of DENV-1.
• DENV-1 Genotype V: Identifies the Genotype V lineage of DENV-1.
• DENV-2 Cosmopolitan Genotype: Detects the highly prevalent Cosmopolitan genotype of DENV-2, frequently associated with severe outbreaks.
• DENV-2 Asian I Genotype: Identifies the Asian I lineage within the DENV-2 serotype.
• DENV-2 Asian II Genotype: Identifies the Asian II lineage within the DENV-2 serotype.
• DENV-2 American/Asian Genotype: Detects the recombinant American/Asian genotype of DENV-2.
• DENV-2 American Genotype: Identifies the ancestral American genotype of DENV-2.
• DENV-3 Genotype I: Detects the Genotype I lineage of DENV-3.
• DENV-3 Genotype II: Detects the Genotype II lineage of DENV-3.
• DENV-3 Genotype III: Identifies the Genotype III lineage of DENV-3, which has been linked to severe epidemics globally.
• DENV-3 Genotype IV: Identifies the Genotype IV lineage of DENV-3.
• DENV-3 Genotype V: Identifies the Genotype V lineage of DENV-3.
• DENV-4 Genotype I: Detects the Genotype I lineage of DENV-4.
• DENV-4 Genotype II: Detects the Genotype II lineage of DENV-4.
• DENV-4 Genotype III: Identifies the Genotype III lineage of DENV-4.
• DENV-4 Sylvatic Genotype: Detects the wild/sylvatic genotype of DENV-4, primarily found in non-human primates.
• Mixed Serotype Infection: Detects co-infection with two or more different dengue serotypes simultaneously (e.g., concurrent DENV-1 and DENV-2 infection).
• Envelope (E) Gene Mutations: Identifies specific nucleotide substitutions in the E gene that may alter viral antigenicity.
• NS1 Gene Variations: Detects genetic variations in the non-structural protein 1 (NS1) gene region.
• Phylogenetic Lineage Classification: Places the detected viral sequence within a specific evolutionary clade on a phylogenetic tree.
• Low Viral Load / Indeterminate Result: Indicates that while viral RNA may be present, the concentration is insufficient to achieve successful sequence amplification and genotyping.

Turnaround Time and Report Access at Chughtai Lab

As a highly specialized molecular biology and genetic assay, the turnaround time for the Dengue Virus Genotyping(For Research Purpose Only) test is longer than routine diagnostic blood tests. Because the procedure involves complex steps including RNA extraction, reverse transcription, PCR amplification, and sequencing (Sanger or Next-Generation Sequencing), the turnaround time typically ranges from 7 to 14 working days, depending on batching requirements and the specific sequencing platform utilized.

Chughtai Lab provides convenient and secure methods for researchers and clinical investigators to access their reports. Once the genotyping analysis is complete and verified by a consultant molecular pathologist, an automated SMS notification is sent to the registered mobile number. Reports can be viewed, downloaded, and printed directly from the official Chughtai Lab website (chughtailab.com) by entering the Patient ID and password provided on the sample collection receipt. Additionally, reports are accessible via the Chughtai Lab Mobile App, ensuring seamless integration of research data for clinicians and academic investigators across Pakistan.

Dengue Virus Genotyping(For Research Purpose Only) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
DENV RNA Detection	Not Detected (Negative)	Detected (Positive for Dengue Virus RNA)
Serotype Identification	Not Applicable / Negative	DENV-1, DENV-2, DENV-3, or DENV-4 detected
DENV-1 Genotyping	Not Applicable / Negative	Genotype I, II, III, IV, or V identified
DENV-2 Genotyping	Not Applicable / Negative	Cosmopolitan, Asian I, Asian II, or American/Asian genotype identified
DENV-3 Genotyping	Not Applicable / Negative	Genotype I, II, III, IV, or V identified
DENV-4 Genotyping	Not Applicable / Negative	Genotype I, II, III, or Sylvatic genotype identified
Co-infection Status	No co-infection detected	Concurrent infection with multiple serotypes (e.g., DENV-1 + DENV-2)
Sequence Quality Metrics	High-quality sequence assembly	Low-quality sequence / Insufficient viral load for genotyping

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Dengue Virus Genotyping(For Research Purpose Only)?

• Experienced Healthcare Professionals: Our molecular biology department is staffed by highly trained molecular biologists, geneticists, and consultant pathologists with extensive experience in viral genomics.
• Patient-Focused Care: We prioritize patient comfort and safety during the sample collection process at all our collection centers.
• Quality Diagnostic Services: Chughtai Lab adheres to international quality standards, ensuring high accuracy, reproducibility, and reliability in all research-grade molecular testing.
• Professional Reporting: We provide comprehensive, detailed molecular reports that include serotype and genotype classification suitable for academic and clinical research.
• Modern Diagnostic Approach: Our laboratories are equipped with state-of-the-art PCR and genetic sequencing platforms to deliver precise genomic data.
• Comfortable Environment: All Chughtai Lab collection centers maintain a clean, hygienic, and comfortable environment for patients.
• Convenient Location: With an extensive network of diagnostic centers and collection points across Pakistan, accessing our services is convenient and accessible.
• Commitment to Accurate Diagnosis: We employ rigorous internal and external quality control protocols to ensure that every research sample is processed with the highest level of scientific integrity.